Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Inovio Pharma (INO)

Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript Motley Fool - Wed Mar 6, 10:30PM CST

INO earnings call for the period ending December 31, 2023.

INO : 10.16 (-2.03%)
Inovio Pharmaceuticals (INO) Q3 2023 Earnings Call Transcript Motley Fool - Thu Nov 9, 2023

INO earnings call for the period ending September 30, 2023.

INO : 10.16 (-2.03%)
Inovio: Q3 Earnings Snapshot AP - Thu Nov 9, 2023

Inovio: Q3 Earnings Snapshot

INO : 10.16 (-2.03%)
INOVIO Announces U.S. FDA Breakthrough Therapy Designation Granted for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis PR Newswire - Thu Sep 7, 2023

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

INO : 10.16 (-2.03%)
Inovio Pharmaceuticals (INO) Q2 2023 Earnings Call Transcript Motley Fool - Wed Aug 9, 2023

INO earnings call for the period ending June 30, 2023.

INO : 10.16 (-2.03%)
Inovio: Q2 Earnings Snapshot AP - Wed Aug 9, 2023

Inovio: Q2 Earnings Snapshot

INO : 10.16 (-2.03%)
INOVIO Announces Second Quarter 2023 Financial Results and Provides Strategic Update PR Newswire - Wed Aug 9, 2023

Preparing to initiate pivotal Phase 3 trial of INO-3107 in adult RRP patients in first quarter of 2024; INO-3107 received Orphan Drug Designation from European...

INO : 10.16 (-2.03%)
INOVIO Reports Inducement Grants Under Inducement Plan PR Newswire - Fri Aug 4, 2023

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

INO : 10.16 (-2.03%)
INOVIO to Report Second Quarter 2023 Financial Results on August 9, 2023 PR Newswire - Wed Jul 26, 2023

/PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

INO : 10.16 (-2.03%)
INOVIO to Present at the 2023 Jefferies Healthcare Conference PR Newswire - Thu May 25, 2023

/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...

INO : 10.16 (-2.03%)

Barchart Exclusives

3 Dividend Aristocrats to Buy on Every Dip Barchart - 1 hour ago
As markets get wobbly, here are three Dividend Aristocrats to add a little stability to any portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot